The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic Approaches

Keyphrases

• Therapeutic Approaches 100%
• Inflammatory Rheumatic Diseases 100%
• Autoimmune Disease 100%
• Cardiac Disease 100%
• Clinical Treatment 100%
• Clinical Aspects 100%
• Systemic Autoimmune Rheumatic Diseases 100%
• Disease Pathophysiology 100%
• Clinically Significant 66%
• Cardiac Complications 66%
• United States 33%
• Novel Therapeutics 33%
• Meta-analysis 33%
• Early Treatment 33%
• Screening Test 33%
• One Country 33%
• Topic-based 33%
• Randomized Clinical Trial 33%
• Clinical Presentation 33%
• Cardiovascular Risk 33%
• Prognostic Implications 33%
• Natural History 33%
• Pathophysiological Processes 33%
• Patient Management 33%
• Myocardium 33%
• Clinical High Risk 33%
• Cardiologists 33%
• Systemic Disease 33%
• American Adults 33%
• Primary Caregivers 33%
• Arthritis 33%
• Underlying Disease 33%
• Novel Therapeutic Targets 33%
• Immunologist 33%
• Expert Views 33%
• Conduction System 33%
• Heart Valve 33%
• High Index of Suspicion 33%
• Coronary Vessels 33%
• Factor Recognition 33%
• Risk Identification 33%
• Pericardium 33%
• Optimal Care 33%
• Rheumatologists 33%
• Therapeutic Change 33%
• Cardiac Manifestations 33%
• Medical Awareness 33%
• Autoimmune Rheumatic Diseases 33%
• Strength of Recommendations 33%
• Advanced Atherosclerosis 33%
• Abnormal Immune Response 33%
• Inflammation Regulation 33%
• Art Collections 33%

Medicine and Dentistry

• Pathophysiology 100%
• Clinical Feature 100%
• Inflammatory Disorder 100%
• Rheumatic Disorder 100%
• Autoimmune Disease 66%
• Heart Disease 66%
• Diseases 66%
• Patient Care 33%
• Awareness 33%
• Prevalence 33%
• Clinical Finding 33%
• Cardiovascular Risk 33%
• Meta-Analysis 33%
• Atherosclerosis 33%
• Arthritis 33%
• Myocardium 33%
• Immune Response 33%
• Randomized Clinical Trial 33%
• Antigen Antibody Complex 33%
• Coronary Vessel 33%
• Screening Test 33%
• Pericardium 33%
• Autoimmune Rheumatic Disease 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Disease 100%
• Pathophysiology 100%
• Rheumatic Disease 100%
• Clinical Feature 100%
• Autoimmune Disease 100%
• Heart Disease 40%
• Diseases 40%
• Inflammation 20%
• Prevalence 20%
• Cardiovascular Risk 20%
• Randomized Clinical Trial 20%
• Atherosclerosis 20%
• Arthritis 20%